Citation

Hornosty J. Bull. Sci. Technol. Soc. 2011; 31(1): 43-54.

Copyright

(Copyright © 2011, SAGE Publishing)

DOI

10.1177/0270467610391292

PMID

unavailable

Abstract

Biotechnology is a rapidly advancing science that has the potential to revolutionize medicine and transform human abilities. Accompanying these positives are an underdiscussed category of threats to principles of human rights and equality. Although any technology might be used to inegalitarian ends, biotechnology has the capacity to beget inequality with a genetic basis. Global regulation is needed to safeguard against the subversion of human rights. However, the intangible nature of the risk combined with the medical possibilities of biotechnology present a significant challenge to achieving international consensus on issues of regulation. An inclusive dialogue that builds on the precedent of current global cooperation initiatives is needed to overcome these challenges. Policies need to be based on a comprehensive consideration of biotechnology’s potential impacts. Evaluating whether the proliferation and integration of a technology is desirable for society is more profitable than assessing the technology’s inherent practical or moral value.